Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — November 2025

Genmab — November 2025

Planlagt Fastgjort Låst Flyttet Genmab
176 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bikube
    wrote on sidst redigeret af
    #148

    Amgen får fuld FDA godkendelse for Imdelltra i SCLC. også iflg. S.A.

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bikube
      wrote on sidst redigeret af
      #149

      Amgen får fuld FDA godkendelse for Imdelltra i SCLC. også iflg. S.A.

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #150

        Epkinly gets a second-line follicular nod And AbbVie and Genmab scoop their ASH presentation with new data.
        https://www.oncologypipeline.com/apexonco/epkinly-gets-second-line-follicular-nod

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #151

          Kesimpta peak salg forventes over 6 milliarder dollars:

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #152

            Link Preview Image
            Novartis venter vækst på 5-6 pct. på mellemlang sigt

            Novartis forventer samtidig, at salget af sklerosemidlet Kesimpta, som Genmab har del i, fortsat når et topsalg på mere end 6 mia. dollar.

            favicon

            (medwatch.dk)

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #153

              Virkelig flot

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #154

                Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street. https://www.investors.com/news/technology/biotech-stocks-antibody-drug-conjugates-adcs-cancer-treatment-chemotherapy/

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #155

                  Transcript : Genmabs præsentation på Jefferies Healthcare Conference med Q&A https://proinvestor.com/investornyt/1385876/transcript-genmabs-praeligsentation-paring-jefferies-healthcare-conference-med-qampa

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #156

                    ASH Late breaker for Teclistamab + Daratumumab
                    https://x.com/JacobPlieth/status/1992984045823942775/photo/1

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #157

                      @Plimsoller looks like only 6 again, i imagine you were probably hoping for something on epco, but this is nice i would say

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #158

                        seems that dump into that large auction follows huge auction in Novo?

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #159

                          ASH25 LBA-6
                          Abstract Title : Phase 3 randomized study of teclistamab plus daratumumab versus investigator’s choice
                          of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients
                          (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3
                          https://meetings-api.hematology.org/api/abstract/vmpreview/304640 Spectacular
                          ...

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            Plimsoller
                            wrote on sidst redigeret af
                            #160

                            @E L Yes, it was epco I had in mind when asking a while back, but this will do 😉 Let's hope for a good run up to ASH this year, and an even stronger finish in 2025.

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              lahn1
                              wrote on sidst redigeret af
                              #161

                              Havde håbet på Epco i DLBC, det havde en kærkommen julegave. Men tænker ikke de vil vente helt til EHA i Juni ??

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                Plimsoller
                                wrote on sidst redigeret af
                                #162

                                Den nyhed er vel kursdrivende, så jeg tror at de kommer med den når data er modne til offentliggørelse? Er der andre bud på det?

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #163

                                  BOFA -GMAB top SMID pick with high conviction in 3 26E catalysts for >$5bn peak https://x.com/semodough/status/1993330204442316888

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    gentogen
                                    wrote on sidst redigeret af
                                    #164

                                    I US og Kina er primary endpoint OS, så det passer nok meget godt, at data skal 'modne'

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      lahn1
                                      wrote on sidst redigeret af
                                      #165

                                      De har vel nået de events der skal til for at data er modne nok. Ellers skulle det måske være for at få en srre adskillelse på Epco og control armen. Men vi ved at endpoint er statistisk signifikant og dermed forskellen til ctrl armen eller hvad ?

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        gentogen
                                        wrote on sidst redigeret af
                                        #166

                                        Ret beset ved vi vel ikke noget, men det hedder, at "Overall Survival (OS) is the primary endpoint in USA and in China, with the analysis population including all randomized participants.". Så måske den slags analyser også bare tager længere tid...

                                        1 Reply Last reply
                                        0
                                        • L Offline
                                          L Offline
                                          lahn1
                                          wrote on sidst redigeret af
                                          #167

                                          Ja ups, den have jeg lige fået forkert registreret.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper